← Return to Has anyone had breast cancer with negative mamograms and no lesions?

Discussion
Comment receiving replies
Profile picture for jmab @jmab

@maymore Isn't Raloxifene, (Evista) primarily an osteoporosis drug? I don't think it's approved for invasive breast cancer treatment. It is only used as a prevention. Yes, fewer side effects than Tamoxifen but still has risk of blood clots. Of course, we can each make our on treatment decisions, whether drug is approved or not. But it might be hard finding an oncologist to prescribe Raloxifene for invasive breast cancer.

Jump to this post


Replies to "@maymore Isn't Raloxifene, (Evista) primarily an osteoporosis drug? I don't think it's approved for invasive breast..."

@jmab - I’ve read several studies stating that Raloxifene was as effective as tamoxifen. That’s why I chose to take it. My endocrinologist shared the Study of Tamoxifen and Raloxifene (STAR) trial, published in 2006 showing that raloxifene is as effective as tamoxifen in reducing the risk of invasive breast cancer in postmenopausal women. It found both drugs reduced risk by about 50%, with raloxifene having a better safety profile, including fewer uterine cancers and blood clots. National Cancer Institute (.gov)